How to Treat Resistant Staphylococcus aureus: Phage Therapy

Antibiotic-resistant Staphylococcus aureus — MRSA included — does not mean a definitive dead end. It means conventional tools have reached their limits, not that every option is exhausted. To treat resistant Staphylococcus aureus, phage therapy uses bacteriophages — natural viruses that specifically target and destroy Staphylococcus aureus. Practised without interruption since 1923 at the Eliava Institute in Tbilisi, Georgia, this method treats the infections antibiotics no longer control: MRSA, osteitis, prosthetic joint infections, chronic wounds.

Why Your Staphylococcus aureus Resists Antibiotics

If your Staphylococcus aureus infection persists despite multiple courses of antibiotics, it is neither your fault nor your doctor’s. Staphylococcus aureus is one of the most difficult bacteria to eradicate, for two specific reasons.

The biofilm. The bacteria form a protective shell, often invisible on imaging, that adheres to your tissue, to bone or to a prosthesis. Inside it, the antibiotic no longer penetrates: the bacteria are not killed, merely dormant, ready to wake the moment treatment stops. This mechanism is documented by the World Health Organization in its factsheet on antimicrobial resistance. It is the central mechanism behind chronic and recurrent infections — understand why an infection returns despite antibiotics.

Acquired resistance. With each course, the fragile bacteria die and the most resistant survive and multiply. MRSA (Methicillin-Resistant Staphylococcus aureus) has become one of the major challenges of hospital medicine worldwide. According to estimates published in The Lancet, antimicrobial resistance is directly linked to around 1.27 million deaths per year globally, and resistant Staphylococcus aureus ranks among the most concerning pathogens.

When your doctor mentions amputation, palliative care, or a “lifelong” infection, they are not wrong: they are saying that with the tools available today in conventional medicine, there is no longer a solution. But there is another tool, one that works in a radically different way — see what sets phages apart from antibiotics.

Does Your Situation Call for Phage Therapy?

Last-line antibiotics (vancomycin, daptomycin, linezolid) remain an option for certain strains. But if you are reading this page, you have probably already tried several lines of treatment without a lasting result.

Here are the situations where an alternative deserves serious consideration:

  • Several courses of antibiotics without lasting eradication
  • Prosthetic joint infection that surgeons are considering removing
  • Chronic osteitis or deep bone infection
  • Chronic wound that will not heal despite local care
  • Recurrent sepsis each time antibiotics are stopped
  • Antibiogram showing resistance to every available molecule
  • Amputation or palliative care raised as the next step

In all these situations, the question of phage therapy deserves to be asked. This is not alternative medicine: it is a documented approach, practised in routine clinical care for over a century, which acts where antibiotics have failed.

If none of these describes your situation — a boil, a recent skin infection, a first course of antibiotics still under way — your own doctor remains the right starting point: phage therapy is for infections that antibiotics no longer control.

If, on the other hand, you recognise yourself in this list, have your case assessed now: complete the medical questionnaire →. No commitment, no cost.

The Anti-Staphylococcal Phages of the Eliava Institute

Bacteriophages target one precise bacterial species without ever affecting human cells or the microbiome — understand how phage therapy works.

When it comes to Staphylococcus aureus, the Eliava Institute is unmatched. S. aureus has been studied by its teams since the 1930s, and the centre holds what is probably the largest collection of anti-S. aureus phages in the world, continuously updated to keep pace with the evolution of resistant strains. It produces, without interruption, several preparations active against staphylococcus:

  • Sb-1 — monovalent staphylococcal phage
  • Pyo phage — polyvalent cocktail that also targets staphylococcus
  • Staphylococcal phage — cocktail specifically directed against staph

Unlike antibiotics, these phages penetrate the biofilm, replicate wherever the bacteria are present, then disappear once the infection is cleared. They cause no cross-resistance with antibiotics and can be combined with them to amplify the effect. Most European countries grant only case-by-case compassionate-use authorisations and produce no phages in routine clinical practice: for a resistant staphylococcus, the Eliava Institute remains the reference centre for foreign patients — discover the Eliava Institute.

How Your Staphylococcus Treatment Works in Tbilisi

The protocol rests on a simple principle: a phage is never applied at random, but the one that kills your specific strain, identified by a sensitivity test — understand the phagogram. For Staphylococcus aureus, it is then the route of administration that changes everything, depending on where the infection sits:

  • Intravenous — staphylococcal sepsis or diffuse deep osteitis.
  • Local application — chronic skin wound, open sinus, fistula, drained abscess.
  • Instillation — directly into an infected prosthetic joint, or as intraoperative irrigation during surgical debridement.
  • Inhalation — colonisation of the airways (cystic fibrosis, chronic bronchitis).
  • Oral — as a complement, when staphylococcus is also present in the digestive tract.

Many cases combine several routes in parallel, decided by the Eliava doctors from your complete file and the mapping of your infection.

Testimonials from Patients Treated for Staphylococcus aureus

Arm saved after 36 operations. After an open fracture and a resistant Staphylococcus aureus infection, this French patient underwent 36 procedures over five years; amputation was the next step being considered. Several cycles of phage therapy at Eliava cleared the infection and restored almost full use of his arm. Read the full testimonial →

Knee prosthesis and septic shock. A Staphylococcus aureus infection on a total knee replacement, followed by septic shock in intensive care; removal of the prosthesis was already scheduled. One cycle of targeted phage therapy stabilised the infection and the prosthesis was kept. Read the full testimonial →

Chronic osteitis and recurrent sepsis. Staphylococcus aureus osteitis lasting several years, with sepsis returning each time antibiotics were stopped. After several stays in Tbilisi, phage therapy ended the relapses and made it possible to taper off long-term antibiotic treatment. Read the full testimonial →

Treated remotely, without travelling. For this patient whose condition ruled out the journey, only the sample was sent to Tbilisi; after the phagogram, personalised phages were shipped for administration at home, under local medical supervision with remote support from Eliava. Read the full testimonial →

Cost and Duration of Treatment

Cost and the organisation of the stay are not specific to staphylococcus: the full breakdown (consultations, phagogram, production of the cocktail, support, interpreter) is on the page how much a phage therapy treatment costs, and everything about the journey (flight, accommodation, transfers, English-speaking interpreter) on the page organising your stay in Georgia. What to keep in mind for a Staphylococcus aureus infection: plan for 14 to 21 days on site as a rule, sometimes with a second cycle a few months later for bone or prosthetic involvement.

Frequently Asked Questions — Staphylococcus aureus and Phage Therapy

Does phage therapy really cure resistant Staphylococcus aureus?

In the majority of cases documented at the Eliava Institute, yes — provided your strain is sensitive to at least one phage in the collection, which the phagogram verifies. No treatment guarantees 100% success, but on antibiotic-resistant Staphylococcus aureus infections, phage therapy achieves results that conventional medicine no longer reaches today.

Can MRSA be treated with phages?

Yes. A bacterium’s resistance to antibiotics has no biological connection with its sensitivity to phages: the two mechanisms are entirely distinct. An MRSA strain that escapes every antibiotic may be perfectly sensitive to Eliava’s phages. This is precisely the ground where phage therapy is most useful.

What is the success rate on staphylococcus in an orthopaedic prosthesis?

Prosthetic joint infections caused by Staphylococcus aureus are among the indications most frequently treated at Eliava, with a century of clinical experience behind them. When the phagogram identifies at least one phage active against your strain, keeping the prosthesis — rather than surgically removing it — is achieved in the majority of cases. In France, the team of Prof. Tristan Ferry (Croix-Rousse Hospital, Lyon) published the first results of the “PhagoDAIR” procedure in 2020 on patients in therapeutic deadlock, confirming on a smaller scale what has been practised daily in Tbilisi for decades.

How long before the first results on a staphylococcus infection?

Clinical improvement is often seen within the first 7 to 14 days: less pain and discharge, a wound gradually closing, inflammatory markers falling (CRP, white cell count). For bone or prosthetic infections, progress is measured over several months.

Wondering whether phage therapy is legal, whether it has side effects, or whether you need to stop antibiotics? Those answers, common to every infection, are gathered on the page what phage therapy treats.

Check Whether Your Staphylococcus aureus Can Be Treated with Phage Therapy

Fill in the medical questionnaire with your latest antibiogram, your most recent bacteriological report and a summary of your history. Alain Lavit forwards your file to the doctors of the Eliava Institute, who tell you within a few days whether phages suited to your strain are available.

Complete the medical questionnaire

No commitment. No fees. No marketing.

About the author

For over 10 years, Alain Lavit has guided European patients towards phage therapy at the Eliava Institute in Tbilisi, of which he is an officially recognised partner, confirmed by letter from the management. He is not a doctor: his role is facilitation — forwarding case files to Eliava’s medical teams, coordinating the stay, and remote follow-up after treatment.

This content is for information purposes. It does not replace medical advice. Any therapeutic decision must be discussed with a healthcare professional. phagetherapygeorgia.eu is a care facilitation service for the Eliava Institute (Georgia) and performs no medical procedures.

Sources